Cancer patients are surviving their disease in increasing numbers, and options to preserve their reproductive health exist for both males and females. Coupling the need of cancer patients with the existing or emerging options from the laboratory is critical to the overall quality of life for survivors. These same fertility interventions also may be applied to men and women facing fertility-threatening nononcologic disease or treatments. Guidance to clinicians is provided by Society guidelines and professional organizations. While not all investigational technologies are available at all locations, and treatment strategies for each disease are constantly changing, the guidance in this chapter provides the most comprehensive series of tools enabling actionable clinician knowledge. The goal of any fertility intervention is to ensure that the primary disease burden is eliminated and that reproductive health is maintained or preserved. These goals are largely possible.
|Original language||English (US)|
|Title of host publication||Yen & Jaffe's Reproductive Endocrinology: Physiology, Pathophysiology, and Clinical Management: Eighth Edition|
|State||Published - Jan 1 2019|
ASJC Scopus subject areas